Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.
about
Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective studyTP53 mutations, expression and interaction networks in human cancersClinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis.Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer.Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner.Combined pretreatment serum CA19-9 and neutrophil-to-lymphocyte ratio as a potential prognostic factor in metastatic pancreatic cancer patients.The prognostic value of p53 positive in colorectal cancer: A retrospective cohort study.
P2860
Q33838679-963B5D9A-849C-474F-9EEC-6368E8445065Q36254626-5F332966-9B60-4498-87B1-558DB9F73C67Q37702327-13AD2B94-6977-4DE1-967B-D803F0D25B56Q37725506-0C8D88B1-DCFB-4A48-9037-AE0241D646BBQ38815842-907553DB-4B38-461D-8E44-4A12A88FCC28Q39269556-CBF1362C-B630-4F96-913D-534414847EBFQ41080806-A39DB6C5-8280-4DE4-9557-9E1A8CE42B65Q49483085-7F235D1A-7927-46E9-B90B-D3FBAF3AEE18Q51022276-4F510DF4-58AC-4894-B211-55704ECE1029
P2860
Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Mutant p53 determines pancreat ...... ive serum CA19-9 ≥ 1,000 U/mL.
@ast
Mutant p53 determines pancreat ...... ive serum CA19-9 ≥ 1,000 U/mL.
@en
type
label
Mutant p53 determines pancreat ...... ive serum CA19-9 ≥ 1,000 U/mL.
@ast
Mutant p53 determines pancreat ...... ive serum CA19-9 ≥ 1,000 U/mL.
@en
prefLabel
Mutant p53 determines pancreat ...... ive serum CA19-9 ≥ 1,000 U/mL.
@ast
Mutant p53 determines pancreat ...... ive serum CA19-9 ≥ 1,000 U/mL.
@en
P2093
P2860
P356
P1433
P1476
Mutant p53 determines pancreat ...... tive serum CA19-9 ≥ 1,000 U/mL
@en
P2093
Chun-Tao Wu
Hua-Xiang Xu
Jiang Long
Jin-Feng Xiang
Jing-Xuan Yang
Quan-Xing Ni
P2860
P2888
P356
10.1038/SREP19222
P407
P50
P577
2016-01-12T00:00:00Z